Outlook 2023: The Irresistible Forces Shaping Medtech Markets And Industry
Market Access Complexities For Medtechs Grow Year On Year But The Essential Success Factors Remain Unchanged
Executive Summary
The integration of smart connected care, broadening of diagnosis and therapy into new settings and improvement of chronic disease outcomes will continue to shape the market for devices and diagnostics companies for years to come. But there is also a maze of short-term macroeconomic issues for medtechs to work through.
You may also be interested in...
The E in ESG: Medtechs Are Getting To Grips With The ‘True Purpose’ Of Carbon Zero
BD and Boston Scientific exemplify the approach of “big medtech” as it knuckles down to meet global climate change responsibilities. But the industry will have to work together with health systems to achieve the larger race to zero goals – especially those of scope 3.
The China Honeymoon Is Over: Global Medtech Must Think Decisively
China is transitioning to an economy driven by innovation and technology, with differential effects on foreign medtechs depending on their place in the value chain and type of innovation. China commentators have been updating the market.
UK LifeSci Funding Boost – Medtech Research And Regulation To Benefit
Rebranded Health Innovation Networks, Biobanks and clinical trials get share of £650m UK funding earmarked to support research, manufacturing, skills development and access to diagnosis and treatment.